AOAC SPSFAM Meeting Book 9-24

9/21/2017

Background on the veterinary drug residue method development project ▪ At that meeting, each member of the advisory panel was invited to speak to their expectations for this initiative. ▪ Beck and Yang of Thermo stated that they want pre-defined methods in this field that they can provide to their customers as well as standards that customers can use to perform the analysis, and they want to contribute their knowledge to the development of a standard. ▪ Delatour of Nestlé explained that they are a global company dealing with raw materials and foods, and they must test raw materials for compliance in many different parts of the world. In general, Nestlé supports the development of standardized analytical methods. Although a method capturing all veterinary drugs would be ideal, they would like to have one that at least covers most of the veterinary drugs in the raw materials they use.

Background on the veterinary drug residue method development project ▪ Holroyd from Fonterra then stated that Fonterra is a dairy company mostly in New Zealand and Australia, and their materials create dairy products all over the world. Fonterra is a large supplier to the global companies. Fonterra wants to ensure that the milk it processes is safe, and harmonization is the key to that. ▪ Wargo from Abbott supported the Fonterra position. ▪ Shringarpure from Tyson advised that they are one of the world’s largest food companies and they are a recognized market leader in meat products. Tyson exports to over 115 countries, and exports require testing for drug residues. Some countries do not recognize the method currently being used and they would really like to see a single multi-residue method

3